Mirae Asset Global ETFs Holdings Portfolio holdings
AUM
$51.7B
1-Year Return
33.71%
This Quarter Return
+3.49%
1 Year Return
+33.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$42.1B
AUM Growth
–
Cap. Flow
+$42.1B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,003
New
3,002
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.67B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.27B |
| 4 |
RSSL
Global X Russell 2000 ETF
RSSL
|
+$1.19B |
| 5 |
Cameco
CCJ
|
+$848M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 27.87% |
| 2 | Industrials | 17.08% |
| 3 | Energy | 12.64% |
| 4 | Materials | 9.54% |
| 5 | Consumer Discretionary | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Edgewise Therapeutics
EWTX
$1.5B
| $527K | ﹤0.01% |
+29,286
| New | +$527K |
|
1802
Day One Biopharmaceuticals
DAWN
$729M
| $526K | ﹤0.01% |
+38,174
| New | +$526K |
|
1803
Herbalife
HLF
$986M
| $524K | ﹤0.01% |
+50,437
| New | +$524K |
|
1804
Collegium Pharmaceutical
COLL
$1.18B
| $524K | ﹤0.01% |
+16,270
| New | +$524K |
|
1805
Protolabs
PRLB
$1.18B
| $523K | ﹤0.01% |
+16,946
| New | +$523K |
|
1806
Compass
COMP
$4.92B
| $521K | ﹤0.01% |
+144,803
| New | +$521K |
|
|
BBT
1807
Beacon Financial Corporation
BBT
$2.17B
| $519K | ﹤0.01% |
+22,778
| New | +$519K |
|
1808
4D Molecular Therapeutics
FDMT
$318M
| $519K | ﹤0.01% |
+24,749
| New | +$519K |
|
1809
ANI Pharmaceuticals
ANIP
$2.12B
| $518K | ﹤0.01% |
+8,135
| New | +$518K |
|
1810
VF Corp
VFC
$5.8B
| $518K | ﹤0.01% |
+38,366
| New | +$518K |
|
1811
German American Bancorp
GABC
$1.53B
| $518K | ﹤0.01% |
+14,643
| New | +$518K |
|
1812
Ralph Lauren
RL
$19.1B
| $514K | ﹤0.01% |
+2,934
| New | +$514K |
|
1813
Fiverr
FVRR
$881M
| $513K | ﹤0.01% |
+21,881
| New | +$513K |
|
1814
Deluxe
DLX
$881M
| $512K | ﹤0.01% |
+22,778
| New | +$512K |
|
1815
Prothena Corp
PRTA
$442M
| $512K | ﹤0.01% |
+24,804
| New | +$512K |
|
1816
National Vision
EYE
$1.82B
| $511K | ﹤0.01% |
+39,048
| New | +$511K |
|
1817
Weis Markets
WMK
$1.75B
| $511K | ﹤0.01% |
+8,135
| New | +$511K |
|
1818
Vital Energy
VTLE
$635M
| $510K | ﹤0.01% |
+11,389
| New | +$510K |
|
1819
Liquidity Services
LQDT
$849M
| $509K | ﹤0.01% |
+25,472
| New | +$509K |
|
1820
Summit Therapeutics
SMMT
$14.1B
| $506K | ﹤0.01% |
+64,818
| New | +$506K |
|
1821
Transcat
TRNS
$697M
| $506K | ﹤0.01% |
+4,225
| New | +$506K |
|
|
PSTX
1822
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $505K | ﹤0.01% |
+173,112
| New | +$505K |
|
1823
Owens & Minor
OMI
$412M
| $505K | ﹤0.01% |
+37,421
| New | +$505K |
|
1824
Fidelis Insurance
FIHL
$1.84B
| $504K | ﹤0.01% |
+30,913
| New | +$504K |
|
|
SPWR
1825
DELISTED
SunPower Corporation Common Stock
SPWR
| $503K | ﹤0.01% |
+169,927
| New | +$503K |
|